GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Antengene Corp Ltd (FRA:722) » Definitions » Accumulated Depreciation

Antengene (FRA:722) Accumulated Depreciation : €0.00 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Antengene Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Antengene's quarterly accumulated depreciation increased from Jun. 2023 (€0.00 Mil) to Dec. 2023 (€-4.28 Mil) but then stayed the same from Dec. 2023 (€-4.28 Mil) to Jun. 2024 (€0.00 Mil).

Antengene's annual accumulated depreciation increased from Dec. 2021 (€-0.66 Mil) to Dec. 2022 (€-2.38 Mil) and increased from Dec. 2022 (€-2.38 Mil) to Dec. 2023 (€-4.28 Mil).


Antengene Accumulated Depreciation Historical Data

The historical data trend for Antengene's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antengene Accumulated Depreciation Chart

Antengene Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated Depreciation
Get a 7-Day Free Trial -0.06 -0.10 -0.66 -2.38 -4.28

Antengene Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2.38 - -4.28 -

Antengene Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.


Antengene Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Antengene's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.


Antengene Business Description

Traded in Other Exchanges
Address
1065 West Zhongshan Road, Suites 1206-1209, Block B, Zhongshan SOHO Plaza, Changning District, Shanghai, CHN
Antengene Corp Ltd is a clinical-stage biopharmaceutical company focused on oncology medicines. The company produces drugs such as selinexor, eltanexor, verdinexor, and other products. It also engages in the discovery, development, manufacturing, and commercialization of first-in-class therapeutics for the treatment of hematologic malignancies and solid tumors. Geographically it operates in Chinese Mainland, Hong Kong, Macao and Taiwan and Overseas.

Antengene Headlines

No Headlines